Other Clinical Trial - A Cross-sectional Investigation on Characteristics

Status Recruiting

Clinical Trial Summary

The investigators will conduct a multicenter cross-sectional study to discover symptom characteristics, quality of life, severity of anxiety and depression, status of lactose intolerance and treatment satisfaction of current Chinese Medicine (CM) regimens of outpatients with FGIDs. In the meanwhile, the investigators will also analyze the characters of CM patterns and corresponding elements, then explore the potential relationship between CM patterns and FGIDs' subtypes.

Clinical Trial Description

This is a multicenter cross-sectional study to discover symptom characteristics, quality of life, severity of anxiety and depression, status of lactose intolerance and treatment satisfaction of current Chinese Medicine (CM) regimens of outpatients with FGIDs. Afterwards, the investigators will explore the potential relationship between CM patterns and FGIDs' subtypes based on collected information. It is estimated that 4,632 outpatients from 18 centers across China will be recruited. Various demographic and disease-related information will be documented, including name, gender, age, education level, marital status, job category, disease course, medical consultation experience, current CM regimens and rationale, and treatment satisfaction. Patients will also complete a series of scales, containing, Rome IV Diagnostic Questionnaire, Patient-Reported Outcome (PRO) scale, the 36-Item Short Form Survey (SF-36), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), lactose food frequency questionnaire (Lactose FFQ) and CM pattern scale. The primary outcome will be the symptom characteristics of outpatients with FGIDs. Secondary outcomes include population characteristics of FGID patients (quality of life, emotional status, lactose intolerance status, and satisfaction level of CM interventions), and potential association between CM patterns and FGIDs' subtypes. ;

Study Design

Related Conditions & MeSH terms

Digestive System Diseases
Functional Gastrointestinal Disorders
Gastrointestinal Diseases

Clinical Trial Details

NCT number	NCT04202588
Study type	Observational [Patient Registry]
Source	Hong Kong Baptist University
Contact	Sonia Low, BNurse
Phone	852-34116523
Email	soniagoh@hkbu.edu.hk
Status	Recruiting
Phase
Start date	January 1, 2020
Completion date	January 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05936112` - Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study	N/A
Completed	`NCT02565355` - Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children	N/A
Completed	`NCT02657668` - Emotion Focused Therapy in Irritable Bowel Syndrome Patients	N/A
Completed	`NCT02731664` - GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans	Phase 1
Recruiting	`NCT06205446` - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction	N/A
Recruiting	`NCT05718960` - Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia	N/A
Terminated	`NCT04247100` - A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders	N/A
Recruiting	`NCT03625674` - Impact of Stigma on Compliance to Medication in Functional Dyspepsia	N/A
Completed	`NCT03252743` - ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.	N/A
Recruiting	`NCT05832528` - Low FODMAP Diet in FD (PDS)	N/A
Completed	`NCT02936713` - Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms	N/A
Terminated	`NCT01712412` - Phase 2a Study of IW-9179 to Treat Functional Dyspepsia	Phase 2
Completed	`NCT00564525` - Study of Medication for Functional Abdominal Pain in Children	Phase 4
Recruiting	`NCT05987813` - Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation	N/A
Completed	`NCT04155801` - A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances	N/A
Recruiting	`NCT05880199` - BSGM to Evaluate Patients With GI Symptoms
Recruiting	`NCT04625881` - Effects of an Apple Derived Fibre Supplement on Constipation	Phase 3
Completed	`NCT03608735` - Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
Recruiting	`NCT04773158` - Systematic Pediatric Assessment of Rome Criteria	N/A
Completed	`NCT02306369` - Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Cross-sectional Investigation on Characteristics of Gastrointestinal Symptoms in China

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms